These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24501748)

  • 1. Subcutaneous golimumab therapy for ulcerative colitis.
    Lowe AW; Moseley RH
    Gastroenterology; 2014 Jan; 146(1):1-2. PubMed ID: 24501748
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):96-109.e1. PubMed ID: 23770005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Still in pursuit.
    Hanauer SB
    Gastroenterology; 2014 Jan; 146(1):13-5. PubMed ID: 24287301
    [No Abstract]   [Full Text] [Related]  

  • 5. [When can TNF-alpha inhibitors against inflammatory bowel disease be withdrawn?].
    Moum B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1673. PubMed ID: 17571118
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial experience with golimumab in clinical practice for ulcerative colitis.
    Castro-Laria L; Argüelles-Arias F; García-Sánchez V; Benítez JM; Fernández-Pérez R; Trapero-Fernández AM; Gallardo-Sánchez F; Pallarés-Manrique H; Gómez-García M; Cabello-Tapia MJ; Talavera-Fabuel A; Bejarano-García A; Leo-Carnerero E; Hernández-Martínez Á; Caunedo-Álvarez Á; Herrerías-Gutiérrez JM
    Rev Esp Enferm Dig; 2016 Mar; 108(3):129-32. PubMed ID: 26786341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].
    Hellström PM; Schmidt D; Karlén P
    Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308
    [No Abstract]   [Full Text] [Related]  

  • 9. Golimumab: clinical update on its use for ulcerative colitis.
    Gilardi D; Fiorino G; Allocca M; Bravatà I; Danese S
    Drugs Today (Barc); 2015 Mar; 51(3):171-84. PubMed ID: 25876561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of ulcerative colitis].
    Vavricka SR; Rogler G
    Praxis (Bern 1994); 2009 Feb; 98(4):209-12. PubMed ID: 19224489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fingolimod-induced remission in a patient with ulcerative colitis and multiple sclerosis.
    Ladrón Abia P; Alcalá Vicente C; Martínez Delgado S; Bastida Paz G
    Gastroenterol Hepatol; 2021 Feb; 44(2):156-157. PubMed ID: 33199131
    [No Abstract]   [Full Text] [Related]  

  • 12. Rescue therapy for steroid refractory acute severe ulcerative colitis: more choice, better outcomes?
    Gearry RB; Falvey JD
    J Gastroenterol Hepatol; 2012 Mar; 27(3):417-8. PubMed ID: 22353345
    [No Abstract]   [Full Text] [Related]  

  • 13. Golimumab for the treatment of ulcerative colitis.
    Flamant M; Paul S; Roblin X
    Expert Opin Biol Ther; 2017 Jul; 17(7):879-886. PubMed ID: 28472597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab for ulcerative colitis.
    Reinshagen M
    N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16575949
    [No Abstract]   [Full Text] [Related]  

  • 15. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis].
    Ainsworth MA; Brynskov J
    Ugeskr Laeger; 2007 Feb; 169(9):789-91. PubMed ID: 17355841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Golimumab Therapy in Ulcerative Colitis].
    Moon W
    Korean J Gastroenterol; 2016 Feb; 67(2):64-73. PubMed ID: 26907481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis.
    Aratari A; Margagnoni G; Koch M; Papi C
    J Crohns Colitis; 2011 Jun; 5(3):262. PubMed ID: 21575893
    [No Abstract]   [Full Text] [Related]  

  • 19. Golimumab in inflammatory bowel diseases: present and future scenarios.
    Dragoni G; Le Grazie M; Orlandini B; Rogai F
    Clin J Gastroenterol; 2019 Feb; 12(1):1-9. PubMed ID: 30206776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients.
    Iborra M; García-Morales N; Rubio S; Bertoletti F; Calvo M; Taxonera C; Boscá-Watts MM; Sierra M; Mancenido N; Beltrán B; Nantes Castillejo Ó; García-Planella E; Vera I; Alba C; Martí-Aguado D; Ballester MP; Cano-Sanz N; Pajares-Villarroya R; Cerrillo E; Cañada A; Nos P
    Sci Rep; 2020 Oct; 10(1):17774. PubMed ID: 33082359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.